Lexicon Pharmaceuticals Newsroom

Citi Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Cuts Target Price to $1.2

Futu NewsNov 28 05:31

Analysts Conflicted on These Healthcare Names: Lexicon Pharmaceuticals (LXRX), Halozyme (HALO) and Crinetics Pharmaceuticals (CRNX)

TipRanksNov 27 13:45

H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $4

Futu NewsNov 26 23:31

Needham Maintains Lexicon Pharmaceuticals(LXRX.US) With Hold Rating

Futu NewsNov 23 02:31

Lexicon Pharmaceuticals Analyst Ratings

BenzingaNov 23 02:03

HC Wainwright Cuts Price Target on Lexicon Pharmaceuticals to $4 From $6, Maintains Buy Rating

MT NewswiresNov 23 00:45

Piper Sandler Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $10

Futu NewsNov 13 21:36

Lexicon Pharmaceuticals (LXRX) Gets a Buy From Piper Sandler

TipRanksNov 13 21:21

H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $6

Futu NewsNov 13 20:35

HC Wainwright & Co. Reiterates Buy on Lexicon Pharmaceuticals, Maintains $6 Price Target

BenzingaNov 13 20:25

Needham Maintains Lexicon Pharmaceuticals(LXRX.US) With Hold Rating

Futu NewsNov 13 18:38

Lexicon Pharmaceuticals Analyst Ratings

BenzingaNov 13 18:23

Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), ICU Medical (ICUI) and Lexicon Pharmaceuticals (LXRX)

TipRanksNov 13 18:22

Lexicon Pharmaceuticals Analyst Ratings

BenzingaNov 5 22:48

H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $6

Futu NewsNov 5 01:31

Lexicon Pharma Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 1 19:10

H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Cuts Target Price to $6

Futu NewsNov 1 18:36

Needham Maintains Lexicon Pharmaceuticals(LXRX.US) With Hold Rating

Futu NewsNov 1 17:33

Leerink Partners Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating

Futu NewsOct 30 20:31

H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $10

Futu NewsOct 30 19:31